International Journal of Hepatology / 2012 / Article / Tab 1

Clinical Study

Milan Criteria and UCSF Criteria: A Preliminary Comparative Study of Liver Transplantation Outcomes in the United States

Table 1

Characteristics of patients within the cohort.

Clinicopathologic factorsN = 1972

Age (yrs)
 Mean ± SD (Range) 56 ± 8 (18–78)
 ≤50 441 (22)
 51–64 1211 (61%)
 ≥65 337 (17%)
Gender
 Female 418 (21%)
 Male1571 (79%)
Diabetes mellitus
 No 1475 (74%)
 Yes*481 (24%)
 Unknown33 (2%)
BMI
 Mean, ±SD 28.1 (4.9)
 Range (13–51)
 <30 1380 (69%)
 ≥30 596 (30%)
 Unknown13 (1%)
Hepatitis B Virus
 Negative 1111 (56%)
 Positive 662 (33%)
 Unknown216 (11%)
Hepatitis C Virus
 Negative 639 (33%)
 Positive 1130 (57%)
 Unknown220 (11%)
Number of tumors
 Mean (range) 1 ± 0.7 (1–5)
 1 1343 (67%)
 2 452 (23%)
 3 191 (10%)
 4 2 (0%)
 51 (0%)
Total Tumor Diameter (cm)
 Mean ± SD (range) 3 ± 1 (0.2–17)
Vital status
 Alive 1479 (74%)
 Dead510 (26%)
COD
 Malignancy recurrence 160 (31%)
 Other 284 (56%)
 Unknown66 (13%)
Liver Directed Therapy
 No 1274 (64%)
 Yes 715 (36%)
Transplant criteria
 Milan 1913 (96%)
 UCSF59 (3%)

*Diabetes mellitus Type I or II; or type unknown.
Radiofrequency ablation, transarterial chemoembolization, cryoablation.
BMI: body mass index; COD: cause of death.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.